Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 21, Issue 5-6, 1996, Pages 473-478

  Takano, H ^a   Sawada, K ^a   Sato, N ^a   Notoya, A ^a   Tarumi, T ^a   Hirayama, S ^a   Koizumi, K ^a   Takahashi, T A ^b   Sekiguchi, S ^b   Koike, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Japanese Red Cross Society   (Japan)

Author keywords

CHOP; Delayed G CSF; Mobilization peripheral blood progenitors; Non Hodgkin's lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL COUNT; COLONY FORMING UNIT GM; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029914669     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609093446     Document Type: Article

References (12)

1. Armitage, J. O., Corder, M. P., Leimert, J. T., Dick, F. R. and Elliot, T. E. (1980) Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) without maintenance therapy. Cancer Treat. Rep., 64, 649-654.
2. Coltman, C. A., Dahlberg, J., Jones, S. E., Miller, T. P., Dana, B. W., Mckelvey, E. M., Hartsock, R. J. and Dixon, D. O. (1986) CHOP is curative in thirty percent of patients with diffuse large cell lymphoma: a twelve year South West Oncology Group Follow Up. Proc. Am. Soc. Clin. Oncol., 5, 197 (abstr).
3. Mckelvey, E. M., Gottlieb, J. A., Wilson, H. E., Arthur, H., Talley, R. W., Stephens, R., Lane, M., Gamble, J. F., Jones, S. E., Grozea, P. N., Gutterman, J., Coltman, C. and Moon, T. E. (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer, 38, 1484-1493.
4. Coleman, M. (1985) Chemotherapy for large-cell lymphoma: optimism and caution. Ann. Intern. Med., 103, 140-142.
5. Shipp, M. A., Harrington, D. P., Klatt, M. M., Jochelson, M. S., Pinkus, G. S., Marshall, J. L., Rosenthal, D. S., Skarin, A. T. and Canellos, G. P. (1986) Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann. Intern. Med., 104, 757-765.
6. Fisher, R. I., Devita, V. T. Jr., Hubbard, S. M., Ihde, D. C., Longe, D. L., Phares, J. C., Jaffe, E. S., Wesley, R. and Young, R. C. (1984) Randomized trial of ProMACE-MOPP vs. ProMACE-CytaBOM in previously untreated, advanced stage, diffuse aggressive lymphomas. Proc. Am. Soc. Clin. Oncol., 3, 242(abstr).
7. Klimo, P. and Connors, J. M. (1985) MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann. Intern. Med., 102,596-602.
8. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E.M., Glick, J.H., Coltman, C.A. and Miller, T.P. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med., 328, 1002-1006.
9. Sawada, K., Sato, N., Kohno, M., Hannda, H., Yasukouchi, T., Tanngo, M., Hirayama, A. and Koike, T. (1995) Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphomas: A pilot study for leukocyte count oriented regimen. Leukemia and Lymphoma, (in press).
10. The Non-Hodgkin's Lymphoma Pathologic classification Project. (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of working formulation for clinical usage. Cancer, 49, 2112-2135.
11. Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. and Tubiana, M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res., 31, 1860-1861.
12. + cells. Blood, 82, 3600-3609.